Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Pneumonia

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Pneumonia in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Pneumonia: Infection of the lung often accompanied by inflammation.

Research Excerpts

ExcerptRelevanceReference
"An 18-week ovalbumin challenge period was performed to generate persistent, chronic asthma in BALB/c mice."3.915-HT ( Battaglia, DM; Cormier, SA; Flanagan, TW; Foster, TP; Nichols, CD; Sebastian, MN, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flanagan, TW1
Sebastian, MN1
Battaglia, DM1
Foster, TP1
Cormier, SA1
Nichols, CD1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Pneumonia

ArticleYear
5-HT
    Life sciences, 2019, Nov-01, Volume: 236

    Topics: Airway Remodeling; Amphetamines; Animals; Asthma; Chronic Disease; Female; Hypersensitivity; Mice; M

2019